PEGLAX ORANGE

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

POLYETHYLENE GLYCOL 3350

Mevcut itibaren:

NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL

ATC kodu:

A06AD15

Farmasötik formu:

POWDER FOR ORAL SOLUTION

Kompozisyon:

POLYETHYLENE GLYCOL 3350 99.365 %W/W

Uygulama yolu:

PER OS

Reçete türü:

Not required

Tarafından üretildi:

BEN SHIMON FLORIS LTD, ISRAEL

Terapötik alanı:

MACROGOL

Terapötik endikasyonlar:

Treatment of constipation.

Yetkilendirme tarihi:

2015-10-31

Bilgilendirme broşürü

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
This medicine is dispensed without a doctor’s prescription
PEGLAX NEUTRAL
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.973% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
PEGLAX ORANGE
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.365% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE.
This leaflet contains concise
information about the medicine. If you have additional questions,
refer to the doctor or the
pharmacist.
Use the preparation according to the instructions in the dosage
section of this leaflet.
Consult the pharmacist if you need more information. Refer to the
doctor if signs of the
ailment (symptoms) worsen or do not improve.
Peglax does not contain sugar and is therefore suitable for diabetics.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for treatment of constipation. Peglax softens
the stool by
increasing the stool water content, causes normal intestinal activity
and thus relieves
constipation.
THERAPEUTIC CLASS:
Osmotic laxative.
2. BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient (polyethylene
glycol 3350) or
to any of the other ingredients this medicine contains (for a list of
inactive
ingredients see section 6 in leaflet – “Additional
information”).
•
You suffer from an intestinal or colon disease (such as ulcerative
inflammation of
the large intestine, Crohn’s disease).
•
You suffer from abdominal pain of undetermined cause.
•
You have or suspect you may have gastrointestinal perforation.
•
You have or suspect you may have bowel obstruction.
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
•
The medicine contains polyethylene glyco